Companies / Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.
ATNMCIK 1388320
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Seth Sandesh Executive | Other Withheld for taxes | Common Stock | $206.7K | -121K -39.59% | 184,481 | low |
| Feb 21, 2014 | Cicic Dragan Executive | Grant Grant or award | Common Stock | $19.4K | +4K | 3,500 | low |
| Aug 17, 2022 | Seth Sandesh Executive | Grant Grant or award | Common Stock | $0 | +300K +5575.17% | 305,381 | low |
| Feb 21, 2014 | Cicic Dragan Executive | Grant Grant or award | Options to purchase common stock | — | +32K | 31,500 | low |
| Feb 18, 2015 | Cicic Dragan Executive | Grant Grant or award | Options to purchase common stock | — | +35K | 35,000 | low |
| Feb 18, 2015 | Traversa Sergio Director | Grant Grant or award | Options to purchase common stock | — | +25K | 25,000 | low |
| Feb 18, 2015 | Dave Kaushik J CEO | Grant Grant or award | Options to purchase common stock | — | +150K | 150,000 | low |
| Sep 23, 2014 | Seth Sandesh Executive | Grant Grant or award | Options | — | +150K | 150,000 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ATNM | common | 00507W206 |